Literature DB >> 17454610

DAT-negative hemolytic anemia in a chronic lymphocytic leukemia patient treated with alemtuzumab.

Giovanni d'Arena, Rosaria de Filippi, Antonio Pinto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17454610     DOI： 10.1080/10428190601101019

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

Review 1.  Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.

Authors:  Anders Osterborg; Claes Karlsson; Jeanette Lundin
Journal:  Curr Hematol Malig Rep       Date:  2009-01       Impact factor: 3.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.